# FDA Approves NRx Pharmaceuticals’ Generic Ketamine Injection

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/44670
Published: 2026-10-30T12:38:19.000Z
Updated: 2026-10-30T12:38:19.000Z
Section: Regulation

> NRx shares rose more than 15% in premarket trading Friday, Oct. 30. The approval may help ease U.S. supply constraints for ketamine used in pain treatment and anesthesia.

The U.S. Food and Drug Administration (FDA) approved NRx Pharmaceuticals’ generic ketamine injection, a decision that may help ease U.S. supply constraints for ketamine used in pain treatment and anesthesia.

NRx Pharmaceuticals shares rose more than 15% in premarket trading Friday, Oct. 30.

Ketamine is used in pain treatment and anesthesia. The approval may help ease supply constraints for those uses in the United States.